TABLE 2.
Timeline of the dynamics of anti‐HEV IgG/IgM antibodies for those patients showing at least one positive result during the study
| Patient ID | Visit 1 (IgG/IgM) | Visit 2 (IgG/IgM) | Visit 3 (IgG/IgM) | Visit 4 (IgG/IgM) | Visit 5 (IgG/IgM) | Visit 6 (IgG/IgM) | Visit 7 (IgG/IgM) | Visit 8 (IgG/IgM) | Visit 9 (IgG/IgM) | Visit 10 (IgG/IgM) | Interpretation |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Pos/Neg | IgG seroconversion | ||||
| 2 | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Pos/Pos | IgG and IgM seroconversion | ||||
| 3 | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Neg/Neg | Neg/Neg | IgG seroreversion | |||
| 4 | Pos/Neg | Pos/Neg | Pos/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | IgG seroreversion | ||
| 5 | Pos/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | IgG seroreversion | ||
| 6 | Pos/Neg | Neg/Neg | Pos/Neg | Neg/Neg | IgG intermittent seroreversion | ||||||
| 7 | Pos/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Neg/Neg | Pos/Neg | IgG intermittent seroreversion | ||||
| 8 | Pos/Neg | Pos/Neg | Pos/Pos | Pos/Neg | Pos/Pos | IgG persistence/ IgM intermittence | |||||
| 9 | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | IgG persistence |
| 10 | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg |
IgG persistence |
| 11 | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg |
IgG persistence |
||
| 12 | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | IgG persistence | |||||
| 13 | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | IgG persistence | ||||||
| 14 | Pos/Neg | Pos/Neg | Pos/Neg | Pos/Neg | IgG persistence | ||||||
| 15 | Pos/Neg | Pos/Neg | Pos/Neg | IgG persistence |
Abbreviations: ID, identification; IgG, immunoglobulin G; IgM, immunoglobulin M; Pos, positive; Neg, negative.